336 related articles for article (PubMed ID: 8832309)
1. Quality of life before and during antihypertensive treatment: a comparative study of celiprolol and atenolol.
Cleophas TJ; van der Mey N; van der Meulen J; Niemeyer MG
Int J Clin Pharmacol Ther; 1996 Jul; 34(7):312-7. PubMed ID: 8832309
[TBL] [Abstract][Full Text] [Related]
2. Quality of life before and during antihypertensive treatment: a comparative study of celiprolol and atenolol.
Cleophas TJ; vd Mey N; Meulen J; Niemeyer MG
Am J Ther; 1997 Apr; 4(4):117-22. PubMed ID: 10423600
[TBL] [Abstract][Full Text] [Related]
3. Quality of life perception during antihypertensive treatment: a comparative study of bisoprolol and enalapril.
Breed JG; Ciampricotti R; Tromp GP; Valster FA; Lageweg E; Van Bortel LM
J Cardiovasc Pharmacol; 1992; 20(5):750-5. PubMed ID: 1280737
[TBL] [Abstract][Full Text] [Related]
4. Different hemodynamic effects of celipropol and atenolol in patients with mild to moderate hypertension.
Saner H; Seiler A; Mahler F
Arzneimittelforschung; 1995 Jul; 45(7):790-5. PubMed ID: 8573224
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of ACE-inhibitors and beta-blockers with and without vasodilating activity in chronic glomerulonephritis.
Erley CM; Klass M; Krämer D; Berger E; Heyne N; Braun N; Wolf S; Risler T
Int J Clin Pharmacol Ther; 1996 Nov; 34(11):504-9. PubMed ID: 8937934
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women.
Applegate WB; Phillips HL; Schnaper H; Shepherd AM; Schocken D; Luhr JC; Koch GG; Park GD
Arch Intern Med; 1991 Sep; 151(9):1817-23. PubMed ID: 1888248
[TBL] [Abstract][Full Text] [Related]
7. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
[TBL] [Abstract][Full Text] [Related]
8. Swedish Isradipine Study in Hypertension: evaluation of quality of life, safety, and efficacy. SWISH Group.
Jern S; Hansson L; Scherstén B; Kullman S; Sörensen S; Dahlöf B; Eggertsen R; Sivertsson R
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S7-8. PubMed ID: 1720487
[TBL] [Abstract][Full Text] [Related]
9. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program.
Applegate WB; Pressel S; Wittes J; Luhr J; Shekelle RB; Camel GH; Greenlick MR; Hadley E; Moye L; Perry HM
Arch Intern Med; 1994 Oct; 154(19):2154-60. PubMed ID: 7944835
[TBL] [Abstract][Full Text] [Related]
10. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
[TBL] [Abstract][Full Text] [Related]
12. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol.
Steiner SS; Friedhoff AJ; Wilson BL; Wecker JR; Santo JP
J Hum Hypertens; 1990 Jun; 4(3):217-25. PubMed ID: 2194029
[TBL] [Abstract][Full Text] [Related]
14. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
Dahlöf B; Devereux R; de Faire U; Fyhrquist F; Hedner T; Ibsen H; Julius S; Kjeldsen S; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H
Am J Hypertens; 1997 Jul; 10(7 Pt 1):705-13. PubMed ID: 9234823
[TBL] [Abstract][Full Text] [Related]
15. The neglected time factor and antihypertensive therapy. A pitfall in evaluating side effects in a cross-over study.
Edmonds D; Greminger P; Vetter W; Baumgart P; Vetter H
Postgrad Med; 1988 Feb; Spec No():40-5. PubMed ID: 2831525
[TBL] [Abstract][Full Text] [Related]
16. [Safety and efficacy of celiprolol in hypertensive patients with chronic obstructive lung disease].
Chahuán M; Corradi L; Román O; Bravo C
Rev Med Chil; 2000 Jan; 128(1):59-63. PubMed ID: 10883523
[TBL] [Abstract][Full Text] [Related]
17. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
Joglekar SJ; Jaguste V; Nanivadekar AS
J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386
[TBL] [Abstract][Full Text] [Related]
18. Comparison of respiratory effects of two cardioselective beta-blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension.
van Zyl AI; Jennings AA; Bateman ED; Opie LH
Chest; 1989 Jan; 95(1):209-13. PubMed ID: 2562825
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial.
Grassi G; Trevano FQ; Facchini A; Toutouzas T; Chanu B; Mancia G
Blood Press Suppl; 2003 Dec; 2():35-40. PubMed ID: 14761075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]